Ann Arbor, Mich. — Eversight, a global non-profit network of eye banks, has awarded an Eye and Vision Research grant to Ula V. Jurkunas, MD (pictured), and Shivakumar Vasanth, PhD. Dr. Jurkunas is a specialist in corneal and refractive surgery at Massachusetts Eye and Ear and an Associate Professor of Ophthalmology at Harvard Medical School and Associate...
Boston, Mass. — The Department of Ophthalmology at Harvard Medical School has been granted a $30,000 Research to Prevent Blindness (RPB) Medical Student Research Fellowship in support of Priya Gupta. This award will allow Gupta to spend one year studying inherited retinal degenerations (IRDs), a devastating cause of blindness throughout the world affecting approximately 1.5 million patients of all ages. She will work under the mentorship of Eric Pierce, MD, PhD...
Boston, Mass. —Lotfi B. Merabet, PhD, OD, MPH, an optometrist and vision researcher at Massachusetts Eye and Ear and an Associate Professor of Ophthalmology at Harvard Medical School, is the 2016 recipient of the Low Vision Research Award from Research to Prevent Blindness (RPB) and the Lions Clubs International Foundation (LCIF). Dr. Merabet will receive $300,000 over three years for...
Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to advance a new gene therapy platform designed to avoid several immunogenicity challenges that limit the development of gene therapies today
Watertown, Mass. — Selecta Biosciences, Inc., a clinical-stage biopharmaceutical...
Mass. Eye and Ear researchers have designed technology to improve upon the built-in zoom feature of smartphones, which many low-vision users find difficult to use due to a loss of context.
BOSTON – Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear/Harvard Medical School have developed a smartphone application that projects a magnified smartphone screen to Google Glass, which users can navigate using head movements...
A complication associated with bone marrow transplantation, graft-versus-host-disease occurs when a transplanted immune system attacks certain parts of a host’s body, and may cause severe dry eye and damage to the cornea. A clinical trial at Massachusetts Eye and Ear showed that topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and showed fewer hypertensive side effects in treating...
Researchers at Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that contribute to optic nerve damage following keratoprosthesis (KPro) implantation in a mouse model. They have also shown that blocking one of the factors, TNFa, leads to a significant decrease in optic nerve cell death, suggesting a new direction for preventing optic nerve damage in patients with keratoprosthesis implants.
Mass. Eye and Ear/Harvard Medical School neuro-ophthalmologist and researcher awarded funding by the Department of Defense Congressionally Directed Medical Research Programs.
Joseph F. Rizzo III, MD, has been awarded grant funding as part of the Vision Prosthesis Pilot Study, a Congressionally Directed Medical Research Program of the United States Department of Defense. Director of Neuro-Ophthalmology at...
Mass. Eye and Ear researchers describe, for the first time, an association between a defective myogenic response of blood vessels in the retina and early, accelerated development of retinopathy in patients with type 1 diabetes. The findings may lead to the development of targeted therapies to delay or prevent the development of diabetic retinopathy in this population.
Mass. Eye and Ear and the Harvard Medical School Department of Ophthalmology are proud to be leading this important clinical trial. We look forward to reporting on safety and efficacy studies in the months and years to come.
ReNeuron announces first patient treated in US Phase I/II clinical trial inblindness-causing disease, retinitis pigmentosa
Marks initiation of ReNeuron’s clinical development activities in the US
ReNeuron Group plc (the “Company”) (AIM: RENE), a leading UK-based stem...
Mass. Eye and Ear researchers describe the role of endomucin, a molecule that – under healthy circumstances – resists the adhesion of white blood cells as they move through the circulatory system. These findings suggest that promoting the expression of endomucin (displayed in red in image) may prevent the collection of white blood cells that causes tissues to become inflamed.
